TORRENT PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 32.5%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets will remain closed on 21st October 2019, due to Assembly Elections in Maharashtra.

TORRENT PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 32.5%
Thu, 25 Jul

TORRENT PHARMA has announced its results for the quarter ended June 2019. Here is a detailed performance review of the same:

TORRENT PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Jun-18*
3
Mar-19*
3
Jun-19*
QoQ ChangeYoY Change
Net SalesRs m18,72018,56020,2208.9%8.0%
Other incomeRs m27017020017.6%-25.9%
TurnoverRs m18,99018,73020,4209.0%7.5%
ExpensesRs m13,95013,83014,8107.1%6.2%
Gross profitRs m4,7701,1605,410366.4%13.4%
DepreciationRs m1,5001,6001,6000.0%6.7%
InterestRs m1,2201,2301,220-0.8%0.0%
Profit before taxRs m2,320-1,5002,79020.3%
TaxRs m690206303050.0%-8.7%
Profit after taxRs m1,630-1,5202,16032.5%
Gross profit margin%25.56.326.8
Effective tax rate%29.7-1.322.6
Net profit margin%8.6-8.110.6
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 8.0% on a year-on-year (YoY) basis. The expenses were up by 6.2% YoY during the same period.
  • The company's operating profit increased by 13.4% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 26.8% in 1QFY20 as against 25.5% in 1QFY19.
  • Depreciation charges increased by 6.7% and finance costs increased by 0.0% YoY, respectively.
  • Other income declined by 25.9% YoY during the quarter.
  • Net profit for the quarter increased by 32.5% YoY. Net profit margins during the quarter increased from 8.6% in 1QFY19 to 10.6% in 1QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 8.9% on a quarter-on-quarter (QoQ) basis. The expenses were up by 7.1% QoQ during the same period.
  • The company's operating profit increased by 366.4% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 26.8% in 1QFY20 as against 6.3% in 4QFY19.
  • Net profit for the quarter increased by 242.1% QoQ, while net profit margins increased from -8.1% in 4QFY19 to 10.6% in 1QFY20.

To see how TORRENT PHARMA has performed over the last eight quarters,please visit here.

TORRENT PHARMA Share Price Performance

Over the last one year,TORRENT PHARMA share price has moved up from Rs 1,476.0 to Rs 1,599.2, registering a Gain of Rs 123.2 or around 8.3%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 12,781.6 (up 1.2%). Over the last one year it has moved down from 13,910.0 to 12,781.6, a gain of 1,128 points (down 8.1%).

Overall, the S&P BSE SENSEX is up 3.3% over the year.

Current Valuations

At the current price of Rs 1,599.2, the price to earnings (P/E) ratio of TORRENT PHARMA stands at 55.4 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 5.9 times.

Equitymaster requests your view! Post a comment on "TORRENT PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 32.5%". Click here!

  

Related Views on News

TORRENT PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 166.7% (Quarterly Result Update)

May 22, 2019 | Updated on May 22, 2019

For the quarter ended March 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 166.7% YoY). Sales on the other hand came in at Rs 19 bn (up 7.8% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 324.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended December 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 324.1% YoY). Sales on the other hand came in at Rs 21 bn (up 38.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Oct 18, 2019 (Close)

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 8-QTR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS